Abstract: A disaggregation system includes a console, the console including a housing, a pod holder plate, a motive applicator mounted in the housing and configured to move the pod holder plate. The system further includes a sample pod configured for holding tissue to be disaggregated, where the sample pod includes a collector component configured for mounting to the pod holder plate; a tissue holder sleeve configured for holding tissue to be disaggregated; and a disaggregation screen. Tissue can be disposed in the sample pod, the sample pod configured to be mounted on the pod holder plate of the console, and when the motive applicator moves the pod holder plate with the pod thereon, tissue in the sample pod configured to be disaggregated into cells.

Abstract: A disaggregation system includes a console, the console including a housing, a pod holder plate, a motive applicator mounted in the housing and configured to move the pod holder plate. The system further includes a sample pod configured for holding tissue to be disaggregated, where the sample pod includes a collector component configured for mounting to the pod holder plate; a tissue holder sleeve configured for holding tissue to be disaggregated; and a disaggregation screen. Tissue can be disposed in the sample pod, the sample pod configured to be mounted on the pod holder plate of the console, and when the motive applicator moves the pod holder plate with the pod thereon, tissue in the sample pod configured to be disaggregated into cells.

Abstract: A cartridge for evaluating the volume of an aliquot of liquid is described. The cartridge can have one or more well tabs that pivot into a position in which liquid dispensed into a corresponding well is placed in contact with a capillary and surface tension draws the liquid from the well into the capillary. Comparison of the liquid-air interface with markings on or near the capillary, can reveal the volume of liquid dispensed. One or more additional features, such as well tabs that are stable in a substantially vertical orientation and/or a groove for protecting and/or self-aligning the capillary can ensure that the device operates properly.

Abstract: A cartridge for evaluating the volume of an aliquot of liquid is described. The cartridge can have one or more well tabs that pivot into a position in which liquid dispensed into a corresponding well is placed in contact with a capillary and surface tension draws the liquid from the well into the capillary. Comparison of the liquid-air interface with markings on or near the capillary, can reveal the volume of liquid dispensed. One or more additional features, such as well tabs that are stable in a substantially vertical orientation and/or a groove for protecting and/or self-aligning the capillary can ensure that the device operates properly.

Abstract: Described herein is the finding that polymerase ? (Pol?) and N-methylpurine DNA glycosylase (MPG) can be used as biomarkers to evaluate the sensitivity of a subject to combination therapy that includes treatment with either temozolomide (TMZ) and methoxyamine, or TMZ and a poly(ADP-ribose) polymerase (PARP) inhibitor. Thus, provided herein is a method of determining if a subject will be sensitive to TMZ and methoxyamine, or TMZ and a PARP inhibitor by measuring expression of Pol? and MPG in a sample from the subject and comparing expression of Pol? and MPG in the sample to a control. A decrease in expression of Pol? and an increase in expression of MPG relative to the control indicates the subject is sensitive to TMZ and methoxyamine, or sensitive to TMZ and the PARP inhibitor.

Abstract: Described herein is the finding that polymerase ? (Pol?) and N-methylpurine DNA glycosylase (MPG) can be used as biomarkers to evaluate the sensitivity of a subject to combination therapy that includes treatment with either temozolomide (TMZ) and methoxyamine, or TMZ and a poly(ADP-ribose) polymerase (PARP) inhibitor. Thus, provided herein is a method of determining if a subject will be sensitive to TMZ and methoxyamine, or TMZ and a PARP inhibitor by measuring expression of Pol? and MPG in a sample from the subject and comparing expression of Pol? and MPG in the sample to a control. A decrease in expression of Pol? and an increase in expression of MPG relative to the control indicates the subject is sensitive to TMZ and methoxyamine, or sensitive to TMZ and the PARP inhibitor.